Submit Manuscript

International Journal of Pharmacology

Year: 2005 | Volume: 1 | Issue: 4 | Page No.: 369-375
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

ABSTRACT

We compared qualitative and quantitatively the neuroprotective effects of ketamine, nimodipine and lamotrigine in rat retinas submitted to acute ischemia and ischemia followed by reperfusion. Ischemia was induced by increasing of intraocular pressure above systolic blood pressure for 60 min. In reperfusion, intraocular pressure was reduced to normal levels for 45 min. Histological evaluation was performed by computer-assisted measurements from histologic sections. Ischemic retinas revealed a decrease in cells densities, cytoplasm vacuolization, pyknotic nuclei, edema and cell disorganization, when compared to contralateral-control eyes. Further, ischemia/reperfusion showed more evident retinal damage when compared to ischemic retinas. Lamotrigine pretreatment (25 mg kg-1) protected neurons mainly in ganglinar cell layer. Nimodipine pretreatment (20 μg kg-1) protected neurons of ganglion cell layer in ischemia and in ischemia/reperfusion the inner nuclear layer. Ketamine pretreatment (20 mg kg-1) protected neurons mainly in outer nuclear layer and inner nuclear layer in ischemia and ischemia/reperfusion. Present results suggest that lamotrigine, nimodipine and ketamine have potential neuroprotective properties in acute ischemia and ischemia/reperfusion models and all of them may have therapeutic implications for retina.
PDF References Citation

How to cite this article

Renato Guizzo, Marcelo Araujo Rodrigues Cairrao, Joaquim Coutinho-Netto, Antonio Renato Meirelles e Silva, Norberto Cysne Coimbra and Wagner Ferreira dos Santos, 2005. Neuroprotection in Acute Ischemia and Ischemia/Reperfusion in Rat Retina. International Journal of Pharmacology, 1: 369-375.

DOI: 10.3923/ijp.2005.369.375

URL: https://scialert.net/abstract/?doi=ijp.2005.369.375

REFERENCES

  1. Leske, M.C., 1983. The epidemology of open-angle glaucoma: A review. Ann. J. Epidemiol., 118: 166-191.
  2. Osborne, N.N., M. Ugarte, M. Chao, G. Chidlow, J.H. Bae, J.P.M. Wood and M.S. Nash, 1999. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Survey Ophthalmol., 43: S102-S128.
  3. Louzada-Junior, P., J.J. Dias, W.F. Santos, J.J. Lachat, H.F. Bradford and J. Coutinho-Netto, 1992. Glutamate release in experimental ischaemia of the retina: An approach using microdialysis. J. Neurochem., 59: 358-363.
  4. Zivin, J.A. and D.W. Choi, 1991. Stroke therapy. Sci. Am., 265: 56-63.
  5. Naskar, R. and E.B. Dreyer, 2001. New horizons in neuroprotection. Survey Ophthalmol., 45: S250-S255.
    Direct Link
  6. Neufeld, A.H., 1999. Nitric oxide: A potential mediator of retinal ganglionar cell damage in glaucoma. Survey Ophthalmol., 43: 129-135.
  7. Osborne, N.N., 1999. Memantine reduces alterations to the mammalian retina, in situ induced by ischemia. Visual Neurosci., 16: 45-52.
    CrossRefDirect Link
  8. Osborne, N.N., C. Cazevieille, A.L. Carvalho, A.K. Larsen, and L. de Santis, 1997. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res., 751: 113-123.
  9. Gehlbach, P.L. and R.L. Purple, 1994. A paired comparison of two models of experimental retinal ischemia. Curr. Eye Res., 8: 597-602.
  10. Crumrine, R.C., K. Bergstrand, A.T. Cooper, W.L. Faison and B.R. Cooper, 1997. Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest. Stroke, 28: 2230-2236.
  11. Yoles, E. and M. Schwartz, 1998. Potential neuroprotective therapy for glaucomatous optic neuropathy. Survey Ophthalmol., 42: 367-372.
  12. Hughes, W.F., 1991. Quantitation of ischemic damage in the rat retina. Exp. Eye Res., 53: 573-582.
  13. Hayreh, S.S. and J.B. Jonas, 2000. Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: An experimental study in rhesus monkeys. Am. J. Ophthalmol., 129: 786-795.
  14. Matini, P., F. Moroni and G. Lombardi, 1997. Ultrastructural and biochemical studies on the neuroprotective effects of excitatory amino acid antagonists in the ischemic rat retina. Exp. Neurol., 146: 419-434.
  15. Lagreze, W.A., R. Knorle, M. Bach and T.J. Feuerstein, 1998. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest. Ophthalmol. Visual Sci., 39: 1063-1066.
    Direct Link
  16. Izumi, Y., K. Shimamoto, A.M. Benz, S.B. Hammerman, J.W. Olney and C.F. Zorumski, 2002. Glutamate transporters and retinal excitotoxicity. Glia, 39: 58-68.
  17. Koinig, H., J.P. Williams, M.J. Quast and M.H. Zornow, 2000. Effect of a neuronal sodium channel blocker on magnetic resonance derived indices of brain water content during global cerebral ischemia. Brain Res., 887: 301-308.
  18. Wiedemann, M. and W. Hanke, 1997. The chicken retina as an experimental model for investigation of central nervous lesions. Neurosci. Lett., 232: 99-102.
  19. Sucher, N.J., S.Z. Lei and S.A. Lipton, 1991. Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res., 551: 297-302.
  20. Karschin, A. and S.A. Lipton, 1989. Calcium channels in solitary retinal ganglion cells from post-natal rat. J. Physiol., 418: 379-396.

Related Articles

Leave a Comment

Your email address will not be published. Required fields are marked *